成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Pharmaceutical intermediates>Bulk Drug Intermediates>7-Chloro-1,2,3,4-tetrahydro-1-(2-methyl-4-nitrobenzoyl)-5h-1-benzazepin-5-one
7-Chloro-1,2,3,4-tetrahydro-1-(2-methyl-4-nitrobenzoyl)-5h-1-benzazepin-5-one
  • 7-Chloro-1,2,3,4-tetrahydro-1-(2-methyl-4-nitrobenzoyl)-5h-1-benzazepin-5-one

7-Chloro-1,2,3,4-tetrahydro-1-(2-methyl-4-nitrobenzoyl)-5h-1-benzazepin-5-one NEW

Price Get Latest Price
Package 1kg 5kg 25kg
Min. Order: 1kg
Supply Ability: 20000
Update Time: 2024-12-23
Related documents: COA

Product Details

Product Name: 7-Chloro-1,2,3,4-tetrahydro-1-(2-methyl-4-nitrobenzoyl)-5h-1-benzazepin-5-one CAS No.: 137982-91-3
Min. Order: 1kg Purity: 99.0%
Supply Ability: 20000 Release date: 2024/12/23

Enki Biopharma initiated the research and development of 'Tolvaptan' in 2009, which has become our most advantageous product. Over the past decade, we have established a series of production chains from the main ring (CAS No.:160129-45-3) to the raw material of Tolvaptan. The annual production capacity of Tolvaptan's main ring is nearly 2 tons, while that of its N-2 intermediate (CAS No.:137977-97-0) is close to 800 kilograms, and the overall production volume of Tolvaptan is around one hundred kilograms. The manufacturing facilities for both Tolvaptan's main ring and N-2 intermediate have undergone audits by numerous domestic and international pharmaceutical companies. Additionally, CMC files can be provided for Tolvaptan's N-2 intermediate."

Company Profile Introduction

Enki Biopharmaceuticals (shanghai) Limited. is a cutting-edge pharmaceutical company committed to the comprehensive exploration, development, manufacturing, and commercialization of top-tier pharmaceutical products. The company established its state-of-the-art technology research and development center in Suzhou City, Jiangsu Province in 2016 and possesses production facilities located in Sichuan Province and Hunan Province. Enki Biopharma is propelled by technological research and development, with a primary focus on the R&D and production of high value-added and high-tech pharmaceutical intermediates/chiral compounds. The ultimate objective is to achieve industrialization through the creation of active pharmaceutical ingredients (APIs), while concurrently establishing core competencies in chiral synthesis, chemical/enzymatic catalysis, and clean production processes. The products primarily target premium foreign markets while simultaneously serving as intermediate support for domestic API production. Enki Biopharma embraces a market-oriented business philosophy, with innovation support and industrialization as its ultimate goals. It upholds the corporate spirit of focus, expertise, innovation, and win-win situations while remaining committed to the mission of creating value for customers, providing opportunities for employees, and promoting human health. Our utmost dedication lies in delivering high-quality products and premium services to our esteemed customers in order to achieve mutual success together. Simultaneously, we strive to foster employee development and promote social harmony.

Recommended supplier

Product name Price   Suppliers Update time
$0.00/10mg
VIP1Y
ShenZhen H&D Pharmaceutical Technology Co., LTD
2024-08-12
$0.00/100kg
VIP1Y
HEBEI BRANT PHARMACEUTICAL CO.,LTD
2024-07-31
$1.00/1g
Cangzhou Wanyou New Material Technology Co.,Ltd
2019-08-04
$2.00/1kg
VIP7Y
Career Henan Chemical Co
2018-12-19
  • Since: 2014-09-10
  • Address: Room 708, Building B(No. 2), No.125 Laiting South Road, Songjiang District, Shanghai,China
INQUIRY